Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 24, 2023
Accession Number:
0001104659-23-035121
Submission Type:
POS AM
CIK:
0000895051
Company Name:
CASI Pharmaceuticals, Inc (DE)
File Number:
333-250801